Systematic Review—Results from En-Bloc Resection of Bladder Cancer
Bladder cancer is the second most common malignancy of the urinary tract and the 9th worldwide. Seventy-five percent are non-muscle invasive and 25% are muscle invasive (Islas-García et al. in Actas Urol Esp 40(4):263–267, 2016). This chapter covers systematic review results in En-Bloc resection of bladder cancer.
- Chen J, Zhao Y, Wang S, Jin X, Sun P, Zhang L, Wang M. Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: a prospective, nonrandomized two-center trial with 36-month follow-up. Lasers Surg Med. 2016;48(9):859–65.CrossRefGoogle Scholar
- Hurle R, Lazzeri M, Colombo P, Buffi N, Morenghi E, Peschechera R, Castaldo L, Pasini L, Casale P, Seveso M, Zandegiacomo S, Taverna G, Benetti A, Lughezzani G, Fiorini G, Guazzoni G. “En bloc” resection of nonmuscle invasive bladder cancer: a prospective single-center study. Urology. 2016;90:126–30.CrossRefGoogle Scholar
- Sureka SK, Agarwal V, Agnihotri S, Kapoor R, Srivastava A, Mandhani A. Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression? A prospective study. Indian J Urol. 2014;30(2):144–9.CrossRefGoogle Scholar
- Wu YP, Lin TT, Chen SH, Xu N, Wei Y, Huang JB, Sun XL, Zheng QS, Xue XY, Li XD. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: a meta-analysis. Medicine (Baltimore). 2016;95(45):5372.CrossRefGoogle Scholar